Bill > S2205

This bill, the Increase Support for Life-saving Endocrine Transplantation Act (ISLET Act), aims to regulate human cadaveric (deceased donor) islets for transplantation as organs. The key provisions of this bill are: 1. Amending the Public Health Service Act to include "human cadaveric islets" as an organ that can be transplanted, alongside existing organs like the pancreas. 2. Clarifying that human cadaveric islets are not considered "drugs," "biological products," or "human cells, tissues, or cellular or tissue-based products (HCT/Ps)" under existing regulations, ensuring they are regulated as organs. 3. Requiring the Secretary of Health and Human Services to update relevant regulations within one year to implement the changes, and to report to Congress on the progress of updating these regulations within six months. The goal of this bill is to provide a regulatory framework that supports the use of human cadaveric islets for life-saving endocrine (hormone-related) transplantations, which can be critical for treating conditions like diabetes.